TNB-486 Elicits 91% CR Rate in Heavily Pretreated, High-Risk...
Teneobio, and LOXO Oncology; he has served on a speaker’s bureau for AstraZeneca, Pharmacyclics, Janssen, AbbVie, SecuraBio, Beigene, and Eli Lilly; he has worked as a consultant or in an advisory role for AstraZeneca, AbbVie, SecuraBio,...